2 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18001025 | Use of Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | GODDARD, LAURA B | 1642 | Non-Final OA | Dec 07, 2022 |
| 17290061 | Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | SITTON, JEHANNE SOUAYA | 1682 | Non-Final OA | Apr 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial